Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass
outcome of diabetic patients in the AWESOME randomized trial and registry
Steven P. Sedlis, MD, FACC*,*,
Douglass A. Morrison, MD, FACC ,
Jeffrey D. Lorin, MD, FACC*,
Rick Esposito, MD*,
Gulshan Sethi, MD, FACC,
Jerome Sacks, PhD ,
William Henderson, PhD,
Frederick Grover, MD, FACC ,
K. B. Ramanathan, MD, FACC||,
Darryl Weiman, MD||,
Jorge Saucedo, MD¶,
Tamim Antakli, MD¶,
Venki Paramesh, MD,
Stuart Pett, MD**,
Sarah Vernon, MD, FACC**,
Vladimir Birjiniuk, MD,
Frederick Welt, MD,
Mitchell Krucoff, MD, FACC,
Walter Wolfe, MD, FACC,
John C. Lucke, MD,
Sundeep Mediratta, MD,
David Booth, MD, FACC||||,
Edward Murphy, MD, FACC¶¶,
Herbert Ward, MD, FACC***,
LaWayne Miller, MD,
Stefan Kiesz, MD, FACC,
Charles Barbiere, CCRN,
Dan Lewis, MD, FACC Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME)
* New York VA Medical Center, New York, New York, USA
Tucson VA Medical Center, Tucson, Arizona, USA
CSPCC Hines VA Hospital, Hines, Illinois, USA
Denver VA Medical Center, Denver, Colorado, USA
|| Memphis VA Medical Center, Memphis, Tennessee, USA
¶ Little Rock VA Medical Center, Little Rock, Arkansas, USA
** Albuquerque VA Medical Center, Albuquerque, New Mexico, USA
West Roxbury VA Medical Center, West Roxbury, Massachusetts, USA
Durham VA Medical Center, Durham, North Carolina, USA
Asheville VA Medical Center, Asheville, North Carolina, USA
|||| Lexington VA Medical Center, Lexington, Kentucky, USA
¶¶ Portland VA Medical Center, Portland, Oregon, USA
*** Minneapolis VA Medical Center, Minneapolis, Minnesota, USA
San Antonio VA Medical Center, San Antonio, Texas, USA
Kansas City VA Medical Center, Kansas City, Kansas, USA
View larger version (17K):
[in a new window]
|
Figure 1 Kaplan-Meier five-year survival curves of coronary artery bypass graft surgery (CABG) (circle) and percutaneous coronary intervention (PCI) (cross) for randomized patients.
|
|
View larger version (18K):
[in a new window]
|
Figure 2 Kaplan-Meier five-year survival curves of CABG (circle) and PCI (cross) for physician-directed patients. Abbreviations as in Figure 1.
|
|
View larger version (17K):
[in a new window]
|
Figure 3 Kaplan-Meier five-year survival curves of CABG (circle) and PCI (cross) for the patient-choice cohort. Abbreviations as in Figure 1.
|
|
View larger version (17K):
[in a new window]
|
Figure 4 Kaplan-Meier curves of CABG (circle) and PCI (cross) five-year survival free of unstable angina for randomized patients. Abbreviations as in Figure 1.
|
|
View larger version (18K):
[in a new window]
|
Figure 5 Kaplan-Meier curves of CABG (circle) and PCI (cross) five-year survival free of unstable angina for physician-directed patients. Abbreviations as in Figure 1.
|
|
View larger version (18K):
[in a new window]
|
Figure 6 Kaplan-Meier curves of CABG (circle) and PCI (cross) five-year survival free of unstable angina for the patient-choice cohort. Abbreviations as in Figure 1.
|
|
View larger version (18K):
[in a new window]
|
Figure 7 Kaplan-Meier curves of CABG (circle) and PCI (cross) five-year survival free of unstable angina and repeat revascularizations for randomized patients. Abbreviations as in Figure 1.
|
|
View larger version (18K):
[in a new window]
|
Figure 8 Kaplan-Meier curves of CABG (circle) and PCI (cross) five-year survival free of unstable angina and repeat revascularizations for physician-directed patients. Abbreviations as in Figure 1.
|
|
View larger version (18K):
[in a new window]
|
Figure 9 Kaplan-Meier curves of CABG (circle) and PCI (cross) five-year survival free of unstable angina and repeat revascularizations for the patient-choice cohort. Abbreviations as in Figure 1.
|
|
|
